Executive summary
DossiMed ("Your medical record, always with you") is a Flutter-based personal health record (PHR) and prescription management platform targeting one of the most underserved geographies in digital health: the 1.4 billion people across Africa, the Arab world, and their diasporas in Europe and North America who carry paper prescriptions, lack a national patient record, and communicate primarily over WhatsApp.
It combines four capabilities that no single competitor in its addressable market currently bundles:
- Azure-powered AI extraction (Document Intelligence + GPT-4o) turning unstructured paper prescriptions, lab results, imaging reports and analyses — whether written in French, Arabic, or English — into structured, queryable records.
- Family-profile architecture with auto-generated treatment plans and dosage-form-specific visual calendars (real icons: pill, half-pill, syrup spoon, drops, sachet, suppository, inhaler, patch).
- Escalation reminder stack — push → WhatsApp → AI voice call (FR/AR/EN) — purpose-built for markets where WhatsApp is the dominant communication channel and push notifications alone underperform on cheap Android devices with intermittent connectivity.
- No-login secure share link letting any doctor open a time-limited, read-only view of a patient's complete medical folder — solving the critical interoperability gap in the majority of African and Arab countries that have no national EHR.
The trilingual stack (FR + AR + EN) is DossiMed's most structurally significant advantage: a single app can serve a Moroccan patient, their Anglophone Nigerian spouse, and their French-resident child — all in one family vault, each in their preferred language. No existing competitor achieves this combination.
The competitive landscape decomposes into six clusters, none of which fully addresses DossiMed's wedge:
| Cluster | Key Players | Core Gap |
|---|---|---|
| National PHRs | Mon Espace Santé, NHS App, My Health Record | Country-bound; no AI OCR; no Arabic/WhatsApp/voice |
| Booking platforms | Doctolib, DabaDoc, Vezeeta, Altibbi | Appointment-first; no AI prescription structuring |
| Medication reminder apps | Medisafe, MyTherapy | No AI ingestion; no Arabic; no WhatsApp/voice escalation |
| Symptom checkers | Ada Health | Adjacent only; no document storage; no adherence |
| Africa-native B2B platforms | Helium Health, mPharma, M-Tiba | Clinic/pharmacy-side; not patient-owned; anglophone-leaning |
| Anglophone-Africa telehealth | Zuri Health, Hello Doctor, mDoc | No PHR; no AI structuring; no francophone/Arabic reach |
Market context
Francophone Africa
Combined population of ~350 million and one of the fastest-growing mobile internet markets globally. No francophone sub-Saharan country has a national patient-owned PHR. WhatsApp penetration reaches 90–97% of connected users — frequently zero-rated by operators (Orange, MTN, Moov).
Anglophone Africa
Nigeria alone: 220 million people, 110 million internet users, ~80 million WhatsApp users. Kenya, Ghana, and South Africa represent additional high-growth markets. All major Africa-native health platforms (Helium Health, mPharma, Zuri Health) are B2B or teleconsultation marketplaces — there is no dominant patient-owned, AI-structured PHR serving anglophone Africa.
The Maghreb
Tunisia reaches 84.9% internet penetration with no national patient-facing digital health record. Morocco has 7.8 doctors per 10,000 inhabitants, with a Shared Medical Record signed in 2024 but still non-operational. Algeria similarly lacks a national PHR. WhatsApp is the primary communication channel across the region.
Broader MENA
Vezeeta and Altibbi serve appointments and teleconsultation but not structured PHR with AI OCR. Arabic is the primary language; existing tools are largely English-first with Arabic as a translation layer. DossiMed's Arabic RTL-first design is a meaningful UX differentiator.
France and the diaspora
Mon Espace Santé (MES) had 24 million activated profiles by early 2026 — but with no AI structuring of user-uploaded documents, no medication adherence engine, and no meaningful support for documents issued outside France. France is home to ~1.5 million Tunisian-origin, ~1.8 million Moroccan-origin, and ~700,000 Algerian-origin residents who travel regularly and need a record that bridges both worlds.
WhatsApp as a healthcare channel
DossiMed's escalation stack — push → WhatsApp → AI voice — is not a novelty feature. It mirrors the actual communication behaviour of the target user. No competitor has built this architecture for a patient-owned PHR in these markets.
Competitor profiles
National and government PHRs
Mon Espace Santé (France) reaches 24 million activated profiles, is free, state-funded, and auto-ingests French prescriptions. However, it has no AI OCR of user-uploaded documents, no escalation reminders, no WhatsApp/voice channel, and no support for documents issued outside France. Doctor sharing requires e-CPS professional authentication — useless for any non-French GP. It is a complement to DossiMed in France, not a competitor.
NHS App (UK) serves 35 million registered users with deep NHS integration but is limited to NHS-registered patients. The entire diaspora population receiving care outside the NHS is excluded. No Arabic, no AI OCR, no multilingual document structuring.
My Health Record (Australia) reaches ~23 million registered Australians via an opt-out model but has notoriously low engagement and no multilingual support.
Booking platforms
Doctolib (France, Germany, Italy) dominates booking and telemedicine in France with 80 million patients. It uses AI for doctor-side consultation summaries, but offers no AI OCR of patient-uploaded prescriptions, no dosing calendar, no WhatsApp escalation, and no Arabic. Its AI feature set is doctor-side, not patient-side.
DabaDoc (Maghreb + 12 African countries) has 5M+ patients and multilingual support (Arabic, French, English). It controls the patient-doctor booking relationship in francophone Africa. DossiMed targets the patient-doctor records relationship — these are adjacent, not overlapping. Partnership potential is high.
Vezeeta (Egypt, KSA, Jordan) is the dominant MENA booking platform with 5M+ users and $200M+ raised. It is not deployed at scale in francophone Africa or the Maghreb and does not build a patient-owned longitudinal PHR.
Altibbi (UAE, Jordan, KSA, Egypt) has the largest Arabic medical-content library and 6M+ teleconsultations. Telehealth-first; no PHR, no AI prescription structuring, no escalation, no francophone or anglophone Africa presence.
Medication management apps
Medisafe is the #1-rated global medication management app with tens of millions of users. But its drug database is US/EU-centric — medications standard in Maghreb and West Africa require full manual entry. No Arabic, no AI OCR, no WhatsApp, no AI voice, no document vault. DossiMed is effectively "Medisafe for the rest of the world."
MyTherapy (Germany) is the closest European functional parallel to DossiMed's reminder layer — but entirely manual, EU-database-limited, and without document management or Arabic support.
Africa-native B2B and telehealth platforms
Helium Health is the dominant anglophone-Africa clinic-side platform across 7 countries with 300,000+ patient visits/month. It is provider-side: patients cannot ingest paper prescriptions from non-Helium clinics. No patient-controlled cross-provider PHR.
Zuri Health (East Africa) delivers healthcare consultations inside WhatsApp — validating the WhatsApp health interface thesis. But it is teleconsultation-only, serves only anglophone East Africa, and has no longitudinal PHR or AI OCR.
mDoc (Nigeria, Ghana) is a WhatsApp-integrated chronic disease management platform — again validating the WhatsApp health channel. Niche in scope, not a general PHR, no French/Arabic.
Africa Smart Health (Morocco) is the closest conceptual parallel to DossiMed in the Maghreb. Direct product testing is recommended before finalising competitive positioning against it; its AI engine and escalation stack remain unverified from public sources.
Competitive gap analysis
| Theme | What incumbents do well | Gaps DossiMed fills |
|---|---|---|
| AI structuring of multilingual paper prescriptions | Doctolib uses GPT-4o doctor-side; Sync.MD has an AI assistant for pre-stored records. | No product ingests patient-uploaded handwritten/printed prescriptions in FR + AR + EN and turns them into structured medication regimens. This is DossiMed's most defensible technical moat. |
| Arabic-language UX + Arabic prescription OCR | Altibbi, Vezeeta, DabaDoc operate in Arabic. | None combines Arabic with a structured PHR + AI OCR + dosing calendar. Medisafe and MyTherapy — the strongest adherence apps — have no Arabic whatsoever. |
| Anglophone Africa PHR | NHS App (UK); My Health Record (AUS); Helium Health (clinic-side). | No patient-owned, AI-structured, cross-border PHR targets anglophone Africa with WhatsApp escalation and a no-login doctor share link. The market is greenfield. |
| Family profiles with full medical folder | Medisafe Medfriend; MyTherapy multi-profile; Apple Health family share. | Medisafe/MyTherapy share medication data only — not the full document folder. None is built around the parent-spouse-child model with full AI-structured document attribution across three languages. |
| Visual dosing calendar with dosage-form icons | Medisafe allows generic icon; MyTherapy uses generic clocks. | Real-form icons (pill, half-pill, syrup spoon, drops, sachet, suppository, inhaler, patch) are unique to DossiMed — particularly valuable for elderly relatives, low-literacy users, and parents managing children's medications. |
| Escalation: push → WhatsApp → AI voice call | Medisafe: push only. Zuri Health and mDoc: WhatsApp teleconsultation (not reminders). | The full escalation stack in FR/AR/EN is structurally unique in markets where push delivery is unreliable and WhatsApp is the dominant communication channel. |
| No-login patient-controlled doctor share link | DabaDoc, Vezeeta, Doctolib require the doctor to have a platform account. MES requires e-CPS. | A time-limited, read-only public link any doctor can open in any browser — without an account — is a major workflow advantage across Africa, MENA, and diaspora contexts. |
| Geographic bridging: Africa ↔ Europe ↔ MENA | No competitor operates meaningfully across all three. | A Nigerian-British, a Moroccan-French, or a Tunisian-Canadian patient can use one app, one record, one family vault, regardless of which country issued the prescription or which language the doctor spoke. |
Differentiation matrix
Legend: ✅ Yes / robust · ⚠ Partial / limited / regional · ❌ No
| Capability | DossiMed | Mon Espace Santé | NHS App | Doctolib | DabaDoc | Medisafe | MyTherapy | Zuri Health | Helium Health |
|---|---|---|---|---|---|---|---|---|---|
| AI OCR of patient-uploaded prescriptions | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| French (FR) | ✅ | ✅ | ❌ | ✅ | ✅ | ❌ | ✅ | ❌ | ❌ |
| Arabic (AR) — RTL-first | ✅ | ⚠ | ❌ | ❌ | ✅ | ❌ | ❌ | ❌ | ❌ |
| English (EN) — full first-class | ✅ | ❌ | ✅ | ❌ | ✅ | ✅ | ✅ | ✅ | ✅ |
| Trilingual FR + AR + EN simultaneously | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| WhatsApp reminder escalation | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ⚠ | ❌ |
| AI voice-call reminders (FR/AR/EN) | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| Family / multi-member profiles | ✅ | ⚠ | ❌ | ⚠ | ❌ | ✅ | ✅ | ❌ | ❌ |
| Auto-generated treatment plan from prescription | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| Visual dosing calendar + dosage-form icons | ✅ | ❌ | ❌ | ❌ | ❌ | ⚠ | ⚠ | ❌ | ❌ |
| No-login doctor share (time-limited link) | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ⚠ | ❌ | ❌ |
| Francophone Africa geography | ✅ | ❌ | ❌ | ❌ | ⚠ | ❌ | ❌ | ❌ | ❌ |
| Anglophone Africa geography | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ✅ | ✅ |
| Maghreb (TN/MA/DZ) | ✅ | ❌ | ❌ | ❌ | ✅ | ❌ | ❌ | ❌ | ❌ |
| Offline-first mobile (Flutter) | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ | ❌ |
| Patient owns + controls data portably | ✅ | ⚠ | ⚠ | ❌ | ❌ | ✅ | ✅ | ❌ | ❌ |
| Free core tier | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ❌ |
DossiMed is the only product in its combined addressable market that simultaneously achieves: AI prescription OCR + Arabic RTL + French + English + WhatsApp escalation + AI voice reminders + dosage-form visual calendar + no-login doctor share + cross-border family profiles + patient-owned data portability. Every competitor checks at most four or five of these dimensions.
Pricing landscape
| App | Free tier | Paid tier | Model | Geography |
|---|---|---|---|---|
| Mon Espace Santé | Full | — | State-funded | France |
| NHS App | Full | — | State-funded | UK |
| Doctolib | Free for patients | €79/mo doctor | B2B SaaS | FR/DE/IT |
| DabaDoc | Free for patients | ~$350/yr doctor | B2B SaaS | Africa/MENA |
| Medisafe | Limited free | $5/mo or $40/yr | Freemium + Pharma | Global (US-centric) |
| MyTherapy | Full free | Minimal | Pharma-partner-funded | EU |
| Helium Health | — | B2B clinic license | B2B SaaS | Anglophone Africa |
| Zuri Health | Free | Per-consult | Telemed B2C | East Africa |
| DossiMed | Core PHR + push reminders | Premium: WhatsApp + AI voice, unlimited family profiles, PDF export, adherence analytics | Freemium B2C | Global (FR+AR+EN) |
DossiMed's freemium structure is well-calibrated for its target markets: the free tier delivers immediate, tangible value in regions with constrained purchasing power, while the premium tier monetises the most engaged users — those managing chronic conditions, elderly relatives, or complex multi-medication families.
Strategic implications
1. The "AI-Arabic-WhatsApp" triangle — the unassailable moat
No incumbent combines all three, and execution requires investments that major competitors have no incentive to make: Azure Document Intelligence on Maghrebi/West-African prescription formats, Arabic RTL product design, and WhatsApp Business API integration at a per-user adherence level. Medisafe (US Pharma-funded), Doctolib (French regulatory focus) and Helium Health (clinic-side B2B) are all structurally prevented from prioritising this combination.
2. English as the anglophone-Africa growth engine
With English as a first-class language — not a translation layer — DossiMed can enter Nigeria, Ghana, Kenya and South Africa without a product rebuild. These four countries alone represent a combined population of ~600 million with rapidly growing smartphone penetration and zero credible patient-owned PHR competitors.
3. In France: complement to Mon Espace Santé, not a substitute
MES will not disappear. The win-zone is users who want active medication adherence MES does not provide, have Maghrebi or sub-Saharan ties, want AI-structured records that work outside the French e-CPS system, or manage elderly parents in North Africa from France.
4. DabaDoc: competitive in booking, complementary in records
DabaDoc controls the patient-doctor booking relationship across francophone Africa and the Maghreb. DossiMed targets the patient-doctor records relationship. A white-label or API partnership is a realistic medium-term commercial avenue.
5. The diaspora flywheel
A Tunisian immigrant in Paris uses DossiMed to manage her own records (France), her elderly mother's prescriptions in Tunis (Maghreb), and her Nigerian-French husband's medication plan (anglophone Africa), then shares the folder with both a French GP and a Tunisian cardiologist via the no-login link. This multi-country, multi-language, multi-provider use case is structurally impossible to serve with any existing competitor. It is DossiMed's most powerful word-of-mouth scenario.
6. Move before Helium Health pivots patient-side
Helium Health is the most likely future entrant into the patient-owned PHR space in anglophone Africa. However, its B2B clinic-side model creates cultural and technical friction toward building a patient-owned, portable product. DossiMed should establish anglophone-Africa presence (Nigeria, Ghana, Kenya) before Helium or mPharma pivots to the consumer side.
Conclusion
DossiMed's defensible moats
- AI structuring of multilingual paper prescriptions in markets where 70–95% of prescriptions remain handwritten or printed and non-digital.
- WhatsApp + AI voice escalation in FR/AR/EN in regions where WhatsApp penetration exceeds 75–97% and is the primary reliable communication channel.
- Secure no-login doctor share bypassing the absent national EHR infrastructure of Tunisia, Morocco, Algeria, Nigeria, Ghana, Kenya, Senegal, and Côte d'Ivoire.
- Trilingual reach (FR + AR + EN) unmatched by any single competitor across this combined geography.
- Offline-first Flutter architecture optimised for intermittent-connectivity Android markets across sub-Saharan Africa.
The competitive landscape across Africa, MENA, France, and the diaspora is fragmented: national PHRs are country-bound; booking platforms are appointment-first; adherence apps are US-centric and manual; B2B platforms serve clinics, not patients. DossiMed occupies a structurally uncrowded position — and the 1.4 billion people in its primary addressable market have never had a tool built for them.